In Vitro Diagnostics Market Size Anticipated to Reach USD 190 billion by 2035

In vitro diagnostics market growth is anticipated at a CAGR of 5.2% during the period 2024-2035

 

According to a recently published report by Roots Analysis, the growing demand for personalized healthcare and the increasing prevalence of chronic disorders are driving the in vitro diagnostics market growth

In Vitro Diagnostics Market Overview

The global In Vitro Diagnostics Market size is estimated to grow at an annualized growth rate of 5.2% during the forecast period 2024-2035 and is expected to reach over USD 190 billion by 2035.

According to the World Health Organization, there are over 40,000 in vitro diagnostics products available in the market, highlighting the critical role of diagnostics in healthcare. Further, it is worth mentioning that over 70% of the healthcare decisions are made based on laboratory test results. This can be attributed to the ability of such solutions to offer precise diagnostics and enable early intervention in order to prevent the progression of a disease. Given the benefits offered by diagnostic solutions to provide rapid diagnostic results and improve patient outcomes, the global in vitro diagnostics market is expected to grow at a healthy compounded annual growth rate (CAGR) during the forecast period.

Browse 150+ figures and 160+ market data tables spread across 180+ pages and detailed Table of Content on “In Vitro Diagnostics Market: Industry Trends and Global Forecasts, till 2035 by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions” here:

https://www.rootsanalysis.com/reports/in-vitro-diagnostics-market.html

Market Drivers

Several factors are propelling the growth of the in vitro diagnostics market. The increasing prevalence of chronic and infectious diseases, such as cancer and COVID-19, has driven the demand for in vitro diagnostic solutions and services. Further, diagnostic tests, biomarker assays, and molecular diagnostics are expected to gain significant traction from the IVD market growth in the coming period. Further, recent technological advancements in the IVD domain, such as next-generation sequencing and digital pathology, have been one of the driving factors of this market. The ability of such solutions to enhance accuracy and speed of diagnosis enable healthcare providers to make more informed diagnostic decisions. Rising healthcare expenditure, fueled by aging populations along with increasing healthcare demands, drive the in vitro diagnostics market growth forward.

Market Restraints

Market restraints are the factors or conditions that can limit the growth and progress of a market. While the in vitro diagnostics market is experiencing substantial growth, it is not without its challenges. One of the primary restraints is the stringent regulatory requirements for the approval of such products. The in vitro diagnostic solutions require compliance of stringent regulatory frameworks, such as FDA approval and CE marking. These frameworks impose strict requirements on the development, validation, and commercialization which requires significant time, resources, and expertise in this domain. Furthermore, setting up IVD facilities requires significant capital and operational expenditure. In addition, diagnostic centers performing such tests need high expenditure, as the instruments required to perform such tests tend to be expensive and require significant expenses in order to navigate through regulatory approvals.

Growth Factors

Despite the challenges, several growth factors are propelling the growth of the in vitro diagnostics market. Primarily, there are a number of strategic collaborations and partnerships that have been signed between IVD manufacturers, diagnostic centers, and research institutions which aim to foster innovation and accelerate the development and adoption of new diagnostic technologies. In addition, the growth of point-of-care testing and at-home testing have significantly expanded the IVD Market. Owing to their ability to provide rapid testing, reducing turnaround times and enabling quicker decision-making, such solutions drive the demand for innovative diagnostic solutions, fueling the IVD Market growth.

In Vitro Diagnostics Market Segments

Based on test type, the market is segmented into laboratory and point-of-care testing.

• The laboratory testing segment led the in vitro diagnostics market, capturing the largest revenue share of 85% in 2024.
• The point-of-care segment is anticipated to show the highest annual growth rate of 8% during the forecast period.

Based on the type of offering, the market is segmented into reagents, instruments, and services.

• The reagents segment led the in vitro diagnostics market, capturing the largest revenue share of 75% in 2024.
• Owing to the intricacies and complexities associated with the development of in vitro diagnostic solutions, this trend is expected to remain the same during the forecast period.

Based on type of technology, the market is segmented into clinical chemistry, hematology, immunoassay, molecular diagnostics, and others.

• The immunoassay technology segment led the in vitro diagnostics market, capturing the largest revenue share of 34% in 2024.
• The molecular diagnostics segment is anticipated to show an annual growth rate of 6.2% during the forecast period.

Based on therapeutic areas, the market is segmented into autoimmune diseases, cardiovascular disorders, diabetes, infectious diseases, renal disorders, oncological disorders, and others.

• The infectious disease segment led the in vitro diagnostics market, capturing the largest revenue share of 41% in 2024.
• The cardiology segment is anticipated to show the highest annual growth rate of 5.6%, during the forecast period.

Based on end users, the market is segmented into hospitals, laboratories, and other end users.

• The hospitals segment led the in vitro diagnostics market, capturing the largest revenue share of 48% in 2024.
• The hospitals segment is anticipated to show an annual growth rate of 5.5% during the forecast period and is expected to hold the majority share of the market in the future, as well.

Based on geographical regions, the market is segmented into North America, Europe, Asia, Latin America, Middle East and North Africa, and Rest of the World

• North America dominated the in vitro diagnostics market and accounted for the largest revenue share of 39.0% in 2024.
• In Asia, the in vitro diagnostics market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The In Vitro Diagnostics Market report also includes detailed profiles of key players (listed below) that offer In vitro diagnostic solutions:

• Abbott Laboratories
• Agilent Technologies
• Becton Dickinson
• bioMérieux
• Bio-Rad
• Danaher Corporation
• DiaSorin
• Exact Sciences
• Fujifilm
• Gold Standard Diagnostics
• Grifols
• Hologic
• Illumina
• LabCorp
• Qiagen
• Quest Diagnostics
• QuidelOrtho
• Roche
• Siemens Healthineers
• Sysmex
• Thermo Fisher Scientific
• Werfen

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/in-vitro-diagnostics-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com